BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2959574)

  • 21. New coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assay.
    Lowe NJ; Breeding JH; Wortzman MS
    Arch Dermatol; 1982 Jul; 118(7):487-9. PubMed ID: 7092274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental and clinical demonstration of the antiproliferative effect of a highly purified coal tar fraction in a special gel vehicle].
    Bernd A; Wehrenberg O; Hevert F; Holzmann H
    Arzneimittelforschung; 1988 Apr; 38(4):582-6. PubMed ID: 3401273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stability of cignolin (dithranol) in ointments containing tar with and without the addition of salicylic acid. Oxidation to danthron and dithranol dimer].
    Müller R; Naumann E; Detmar M; Orfanos CE
    Hautarzt; 1987 Feb; 38(2):107-11. PubMed ID: 3570777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical psoriasis therapy.
    Federman DG; Froelich CW; Kirsner RS
    Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect on epidermal DNA synthesis of a combination of topical steroid with either dithranol or tar as used for psoriasis.
    Clement M; Hehir M; Phillips H; du Vivier A
    Br J Dermatol; 1983 Sep; 109(3):327-35. PubMed ID: 6615719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis.
    Morhenn VB; Orenberg EK; Kaplan J; Pfendt E; Terrell C; Engleman EG
    J Invest Dermatol; 1983 Jul; 81(1):23-7. PubMed ID: 6863976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies.
    Noonan FP; Bucana C; Sauder DN; De Fabo EC
    J Immunol; 1984 May; 132(5):2408-16. PubMed ID: 6232317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical antipsoriatic agents and epidermal mitosis in man.
    Fisher LB; Maibach HI
    Arch Dermatol; 1973 Sep; 108(3):374-7. PubMed ID: 4729761
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anthralin-salicylic acid therapy of psoriasis. Cignolin-salicylic acid-vaseline treatment and Lasan paste in a right-left comparison].
    Runne U
    Hautarzt; 1974 Apr; 25(4):199-200. PubMed ID: 4848053
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tar treatment of psoriasis].
    Goerz G; Merk H; Hölzle E
    Hautarzt; 1985 Jan; 36(1):50-3. PubMed ID: 3972580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation.
    Peus D; Beyerle A; Vasa M; Pott M; Meves A; Pittelkow MR
    Exp Dermatol; 2004 Feb; 13(2):78-85. PubMed ID: 15009100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
    Mutat Res; 1981 May; 86(3):279-304. PubMed ID: 7029262
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of psoriasis.
    Bryant BG
    Am J Hosp Pharm; 1980 Jun; 37(6):814-20. PubMed ID: 6994496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fexofenadine downmodulates antigen-presenting ability of murine epidermal Langerhans cells.
    Sugita K; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jan; 49(1):88-91. PubMed ID: 17950577
    [No Abstract]   [Full Text] [Related]  

  • 35. The treatment of psoriasis.
    Watson A
    Aust Fam Physician; 1985 Oct; 14(10):1082-3. PubMed ID: 4084130
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mecortolon tar in the treatment of psoriasis].
    Nowak A; Baran E; Jacyk W
    Pol Tyg Lek; 1972 Sep; 27(36):1407-9. PubMed ID: 4562339
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of psoralen with solar ultraviolet light (puvasol) and adjunctive topical tar therapy in psoriasis.
    Kar PK; Jha PK; Snehi PS
    J Indian Med Assoc; 1994 Apr; 92(4):120-1. PubMed ID: 8083550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Initial experiences with Locacorten-Tar, a new combination preparation for the external treatment of psoriasis].
    Krebs A; Mischler M; Kuske H
    Schweiz Med Wochenschr; 1967 Feb; 97(5):151-5. PubMed ID: 5591345
    [No Abstract]   [Full Text] [Related]  

  • 39. Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity.
    Rheins LA; Nordlund JJ
    J Immunol; 1986 Feb; 136(3):867-76. PubMed ID: 3079801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psoriasis phototherapy. Antipsoriatic efficacy of 8-methoxypsoralen and tar baths].
    Rowe E; Meffert H; Miehe M; Sönnichsen N
    Dermatol Monatsschr; 1985; 171(3):180-4. PubMed ID: 3996697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.